Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Open Access
- 1 February 2007
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 102 (2), 814-816
- https://doi.org/10.1152/japplphysiol.01208.2006
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASISJournal of Applied Physiology, 2007
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood, 2005
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exerciseBiochemical and Biophysical Research Communications, 2004
- Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 DiabetesThe New England Journal of Medicine, 2004
- Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humansThe FASEB Journal, 2003
- SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2Journal of Biological Chemistry, 2002
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide TreatmentDiabetes Care, 1998
- Interleukin-6 Enhances Glucose Transport in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1996